Comments for Spectrum Pharma (NASDAQ:SPPI): Undervalued Based on Late-Stage Pipeline at http://www.biomedreports.com , comment 1 to 2 out of 2 comments http://www.biomedreports.com Thu, 24 May 2012 19:49:11 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/200906191457/spectrum-pharma-nasdaqsppi-undervalued-based-on-late-stage-pipeline.html#comment-354 Nicely written article with examples to back up your conclusions. Thanks for the information! - Gloria Johnson Fri, 19 Jun 2009 00:49:11 +0100 http://www.biomedreports.com/200906191457/spectrum-pharma-nasdaqsppi-undervalued-based-on-late-stage-pipeline.html#comment-352 what do you think the share price will be after zevalin approval - rgard32 Fri, 19 Jun 2009 00:15:15 +0100